Retatrutide Shows Promising Weight Loss in Phase 3 TRIUMPH-1 Study | Retatrutide News

Retatrutide achieved up to 30.3% average weight loss in the Phase 3 TRIUMPH-1 trial. This significant result highlights its potential impact in obesity ...
Clinical Trials · November 5, 2026